2025 Seattle Cellular Therapy Summit
This CME-accredited activity, 2025 Seattle Cellular Therapy Summit, features leading experts who will provide a comprehensive overview of current and emerging strategies for the management of lymphoma, myeloma, acute leukemias, and solid tumors with a focus in the use of cellular therapies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies and to describe potential future applications of cellular therapy in solid tumors. The activity will use a mix of didactic lectures and case-based discussions to highlight areas of debate between cellular therapy and non-cellular therapy in the treatment of these diseases. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care. The faculty will discuss barriers to using cellular therapy and discuss evidence-based strategies to navigate these barriers to incorporate the new standards of care in managing patients with cancer.
The symposium will augment healthcare providers' foundation of knowledge and clinical competence in several areas:
- Providing a review of existing clinical evidence supporting approved Chimeric Antigen Receptor T-cell (CAR T) therapies in the care of patients with hematologic malignancies
- Describing the role of non-cellular therapies in hematologic malignancies
- Identify challenges to the delivery of cellular therapies and provide a discussion on how such barriers may be addressed
- Discussing novel investigational approaches of cellular therapy in acute myeloid leukemias and solid tumors
Organizing Committee
Conference Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Co-Chairs:
Mazyar Shadman, MD, MPH - Fred Hutchinson Cancer Center & University of Washington
Krish Patel, MD - Swedish Cancer Institute
Target Audience
- Hematologists/Medical Oncologists
- Oncology fellows
- Oncology nurses
- NPs/PAs
- Oncology pharmacists
Learning Objectives
Upon successful completion of this educational activity, participants will be able to:
- Review indications and outcomes of approved cellular therapies in hematologic malignancies
- Identify emerging cellular therapies in hematologic malignancies and solid tumors
- Identify and manage complications after cellular therapy
- State the financial, physical, and other barriers, review strategies to navigate these factors to optimize the management of patients with cellular therapies
GLOBAL ONCOLOGY PROJECT
Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/
DAY 1 – Friday, August 15, 2025
All times are listed in Pacific Time (PT)
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 8:30 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:30 AM – 10:00 AM Session 1
Session Chair:
08:30 AM – 08:45 AM Topic 1
08:45 AM – 09:00 AM Topic 2
09:00 AM – 09:15 AM Topic 3
09:15 AM – 09:45 AM Panel Discussion
09:45 AM – 10:00 AM Break & Exhibits
10:00 AM – 12:00 PM Session 2:
Session Chair:
10:00 AM – 10:15 AM Topic 1
10:15 AM – 10:30 AM Topic 2
10:30 AM – 10:45 AM Topic 3
10:45 AM – 11:00 AM Topic 4
11:00 AM – 11:15 AM Topic 5
11:15 AM – 12:00 PM Panel Discussion
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 02:00 PM Session 3
Session Chair:
01:00 PM – 01:15 PM Topic 1
01:15 PM – 01:30 PM Topic 2
01:30 PM – 01:45 PM Topic 3
01:45 PM – 02:00 PM Topic 4
02:00 PM – 02:15 PM Break & Exhibits
02:15 PM – 03:00 PM Session 4
Session Chair:
02:15 PM – 02:30 PM Topic 1
02:30 PM – 02:45 PM Topic 2
02:45 PM – 03:00 PM Panel Discussion
03:00 PM – 04:00 PM Breakout Session
06:00 PM – 09:00 PM Argosy Cruise
Email [email protected] to rsvp
**Open to all non-industry attendees**
**This is a non-CME activity**
DAY 2 – Saturday, August 16, 2025
07:00 AM – 08:00 AM Registration, Breakfast, & Exhibits
08:00 AM – 08:15 AM Welcome
08:15 AM – 10:20 AM Session 5: Debates
Session Chair:
Which Immunotherapy Target is Optimal for DLBCL?
08:15 AM – 08:20 AM Case Presentation
08:20 AM – 08:30 AM Speaker 1
08:30 AM – 08:40 AM Speaker 2
CAR-T Therapy vs. Bispecific Antibodies - Which FL Treatment Approach is Superior?
08:40 AM – 08:50 AM Speaker 1
08:50 AM – 09:00 AM Speaker 2
Is Transplant the Best Approach for MCL?
09:00 AM – 09:05 AM Case Presentation
09:05 AM – 09:15 AM Speaker 1
09:15 AM – 09:25 AM Speaker 2
09:25 AM – 09:35 AM Speaker 3
09:35 AM – 09:50 AM Topic
09:50 AM – 10:20 AM Panel Discussion
10:20 AM – 10:35 AM Break & Exhibits
10:35 AM – 12:00 PM Session 6: Debates
Session Chair:
Topic 1:
10:35 AM – 10:40 AM Case Presentation
10:40 AM – 10:50 AM Speaker 1
10:50 AM – 11:00 AM Speaker 2
Topic 2:
11:00 AM – 11:05 AM Case Presentation
11:05 AM – 11:15 AM Speaker 1
11:15 AM – 11:25 AM Speaker 2
Topic 3:
11:25 AM – 11:35 AM Speaker 1
11:35 AM – 11:45 AM Speaker 2
11:45 AM – 12:00 PM Panel Discussion
12:00 PM – 01:00 PM Lunch & Exhibits
01:00 PM – 03:00 PM Session 7: Debates
Session Chair:
Topic 1:
01:00 PM – 01:05 PM Case Presentation
01:05 PM – 01:15 PM Speaker 1
01:15 PM – 01:25 PM Speaker 2
01:25 PM – 01:35 PM Speaker 3
Topic 2:
01:35 PM – 01:45 PM Speaker 1
01:45 PM – 01:55 PM Speaker 2
Topic 3:
01:55 PM – 02:05 PM Speaker 1
02:05 PM – 02:15 PM Speaker 2
02:15 PM – 03:00 PM Panel Discussion
03:00 PM – 03:15 PM Break & Exhibits
03:15 PM – 04:40 PM Session 8: Debates
Session Chair:
03:15 PM – 03:30 PM Speaker 1
Topic 1:
03:30 PM – 03:40 PM Speaker 1
03:40 PM – 03:50 PM Speaker 2
Topic 2:
03:50 PM – 03:55 PM Case Presentation
03:55 PM – 04:05 PM Speaker 1
04:05 PM – 04:15 PM Speaker 2
Topic 3:
04:15 PM – 04:20 PM Case Presentation
04:20 PM – 04:30 PM Speaker 1
04:30 PM – 04:40 PM Speaker 2
04:40 PM Adjourn

Hotel Reservation Details Coming Soon!
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Krish Patel, MD
Mazyar Shadman, MD,MPH
Available Credit
- 11.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 11.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 11.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.25 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
REGISTRATION FEES
Physicians (non-industry) - $300
Non-physician HCP (non-industry) - $200
Industry representatives - $1250
If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:
Link to register as an additional rep of a sponsoring company: https://education.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
Attend Only Registration Terms & Conditions:
Employees of companies that have not purchased an exhibit space or are not a sponsor of the conference should refrain from interacting with healthcare provider attendees outside of the main meeting room. This applies to ALL interactions except for asking content-relevant questions to faculty inside the meeting room where the CME-accredited activity occurs. Please do not engage in product promotion activity with any attendees or faculty of the conference.
If your company has not purchased an exhibit space or sponsorship, and you engage in any promotional activity, including but not limited to introducing yourself to healthcare providers as an employee of the company, handing out business cards and product brochures/flyers, setting up visits/appointments, inviting them to promotional talks, etc., we will invoice YOU for the full cost of a premium exhibit table.
If your company has not purchased an exhibit space or sponsorship, please limit your interaction with healthcare providers attending this conference to "hello" only if you know the provider. Failure to comply with this requirement may result in being banned from all future conferences.
Employees of companies who are not exhibiting or sponsoring the conference may not enter the exhibit area. The exhibit area is ONLY for exhibitors and sponsors to engage in sales activity. Many of our conferences have meals in the exhibit hall; if the meal is in the exhibit hall, you will need to make alternative arrangements for your meals as you will not be provided meals by the meeting.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post-tests as well as course evaluations.